Abgenix Inc., of Fremont, Calif., named John Meyer vice president, human resources, and Gayle Mills vice president, business development.
AeroGen Inc., of Sunnyvale, Calif., elected Susan Desmond-Hellman to its board of directors. Desmond-Hellman is executive vice president and chief medical officer of Genentech Inc.
Atairgin Technologies Inc., of Irvine, Calif., said William Garland joined the company as vice president of scientific affairs.
Axys Pharmaceuticals Inc., of South San Francisco, named Michael Green vice president of medicinal chemistry.
Biosyntech Inc., of Montreal, named Marie-Claire Pilon as CEO.
Cell Genesys Inc., of Foster City, said Nancy Crowell joined its board of directors.
Cyclacel Ltd., of Dundee, Scotland, named Robert Westwood head of preclinical development.
Discovery Laboratories Inc., of Doylestown, Pa., made Deni Zodda senior vice president, business development.
Galapagos Genomics NV, of Mechelen, Belgium, appointed Dirk Pollet vice president of business development.
Genaissance Pharmaceuticals Inc., of New Haven, Conn., appointed Kenneth Kashkin executive vice president and chief medical officer.
Genomics Collaborative Inc., of Cambridge, Mass., named Art Williams chief information officer and Kristin Ardlie vice president of genetics.
Iconix Pharmaceuticals Inc. said Rudyard Istvan joined its board of directors.
Immunex Corp., of Seattle, said Leslie Garrison will lead its clinical development programs as senior vice president, clinical development.
Immusol Inc., of San Diego, appointed Flossie Wong-Staal vice president of genomics.
Isis Pharmaceuticals Inc., of Carlsbad, Calif., elected B. Lynne Parshall to its board of directors.